Aktive Positionen von Konstantina Katcheves
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MIRATI THERAPEUTICS | Direktor/Vorstandsmitglied | 23.01.2024 | - |
| RAYZEBIO, INC. | Direktor/Vorstandsmitglied | 26.02.2024 | - |
| KARA THER | Direktor/Vorstandsmitglied | 18.03.2024 | - |
Karriereverlauf von Konstantina Katcheves
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director/Board Member | 3 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RAYZEBIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Konstantina Katcheves
- Erfahrung